Evaluation of men’s knowledge, attitudes, and performance toward Prostate Cancer in the Urology Clinic of Imam Khomeini Hospital, Urmia, Iran
Men's Health Journal,
Vol. 6 No. 1 (2022),
,
Page e10
https://doi.org/10.22037/mhj.v6i1.37393
Abstract
Introduction: Prostate cancer is the second most common cancer after lung cancer worldwide. In 2018, there were 1276106 new cases and 3.8% (358989 cases) of the population who died of this cancer were men. (What do you mean? All were men because we are talking about prostate cancer, but do you mean the mortality rate?) We aimed to evaluate men's knowledge, attitudes, and performance toward prostate cancer. Materials and Methods: A descriptive analysis was done on 385 men in the urology clinic of Imam Khomeini Hospital. Men aged at least 40 with no history of prostate cancer were included in this survey. The researchers made a questionnaire including two parts: the first part comprised information about knowledge, attitudes, performance, and the second part consisted of demographics. The men’s function was divided into two groups according to performing the PSA test: the good function group (PSA tests were done) and the weak function group (PSA tests were not done). Data analyzed were analyzed using SPSS software, version 20. Results: The mean±SD age of the men was 63.9±8.9 years and 56.6% of them were city dwellers. 22.7% had a university degree. Most (38.5%) were Self-employed and most (76.3%) had no family history of prostate cancer. Most participants answered the general questions about prostate cancer, but they did not have suitable and reliable information about related risk factors, diet, and sexual activity. Conclusion: Considering the positive effect of people's knowledge on their attitude and their attitude on their performance, by holding training classes and education for people at risk their attitude and ultimately their performance towards prostate cancer prevention would be improved.
- Prostate Cancer
- Knowledge
- Attitude
- Men’s health
- Urology
How to Cite
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018;68(6):394-424.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet‐Tieulent J, Jemal A. Global cancer statistics, 2012. CA: a cancer journal for clinicians. 2015;65(2):87-108.
Pakzad R, Rafiemanesh H, Ghoncheh M, Sarmad A, Salehiniya H, Hosseini S, et al. Prostate cancer in Iran: trends in incidence and morphological and epidemiological characteristics. Asian Pacific Journal of Cancer Prevention. 2016;17(2):839-43.
BRAY, Freddie; KIEMENEY, Lambertus A. Epidemiology of prostate cancer in Europe:patterns,trends and determinants.in:Management of prostate cancer Springer,Cham,2017.p.1-27.
HASSANIPOUR, Soheil; FATHALIPOUR, Hamid. the incidence of prostate cancer in iran:a systematic review and metaanalysis .prostate international,2018,6.2:41-45
Autorino R, Di Lorenzo G, Damiano R, Giannarini G, De Sio M, Cheng L, et al. Pathology of the prostate in radical cystectomy specimens: a critical review. Surgical Oncology. 2009;18(1):73-84.
Hosseini S, Danesh A, Parvin M, Basiri A, Javadzadeh T, Safarinejad M, et al. Incidental prostatic adenocarcinoma in patients with PSA less than 4 ng/mL undergoing radical cystoprostatectomy for bladder cancer in Iranian men. International braz j urol. 2007;33(2):167-75.
Hoffman RM. Screening for prostate cancer. New England Journal of Medicine. 2011;365(21):2013-9.
Olapade-Olaopa EO, Obamuyide HA, Yisa GT. Management of advanced prostate cancer in Africa. The Canadian journal of urology. 2008;15(1):3890-8.
Dawam D, Rafindadi A, Kalayi G. Benign prostatic hyperplasia and prostate carcinoma in native Africans. BJU international. 2000;85(9):1074-7.
Rezaeian M, Tabatabaei Z, Naeimi R, Esmaeili A, Jamali M, VaziriNejad R, et al. Knowledge, attitude and practice of Rafsanjan male pensioners towards prevention of prostate cancer in the year 2006. The Horizon of Medical Sciences. 2007;12(4):19-25.
Marashi T, Razaghi M, Khodakarim S, Balvayeh M. Surveying the awareness of male hospital staffs about prostate cancer screening in selected hospitals of Shahid Beheshti university of medical sciences in 2017. Paramedical Sciences and Military Health. 2018;12(4):54-61.
Rawla P. Epidemiology of prostate cancer. World journal of oncology. 2019;10(2):63.
Mirone V, Imbimbo C, Arcaniolo D, Franco M, La Rocca R, Venturino L, et al. Knowledge, attitudes, and practices towards prostate cancer screening amongst men living in the southern Italian peninsula: the Prevention and Research in Oncology (PRO) non-profit Foundation experience. World journal of urology. 2017;35(12):1857-62.
Ghanbari A, Rahmatpour P, Khalili M, Mokhtari N. Health literacy and its relationship with cancer screening behaviors among the employees of Guilan University of Medical Sciences. Journal of Health and Care. 2017;18(4):306-1
Tayyebi azar A, Fallah-Karkan M, Hosseini MA, Kazemzadeh azad B, Heidarzadeh A, Hosseini J. Persian version of Patient-Reported Outcome Measure for Urethral Stricture Surgery (USS-PROM) Questionnaire, Validation and Adaptation Study. Urology Journal. 2020;17(1): 61-67.
- Abstract Viewed: 112 times
- pdf Downloaded: 53 times